Suchergebnisse
NetScout Systems Q1 Earnings Call Highlights
NetScout Systems (NASDAQ:NTCT) reported first-quarter fiscal 2027 revenue growth of 13%, citing demand for its service assurance offerings, government-related orders and contributions from its
Ouster Q2 Earnings Call Highlights
Ouster (NASDAQ:OUST) reported second-quarter revenue of $55 million, up approximately 56% from a year earlier, as demand from
Organogenesis Q2 Earnings Call Highlights
Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year decline in second-quarter revenue as the skin substitute market continued to adjust to coverage and payment changes from the Centers for
Nexstar Media Group Q2 Earnings Call Highlights
Nexstar Media Group (NASDAQ:NXST) reported record second-quarter results as revenue nearly reached $2 billion, aided by its acquisition of
PAYC Q2 Earnings Call Centers on Automation and Raised Outlook (Revised)
Paycom Software, Inc. PAYC used its second-quarter 2026 call to frame automation as a driver of client value and internal efficiency. Management raised its full-year revenue and adjusted EBITDA
Stock Market News for Aug 7, 2026
Wall Street closed lower on Thursday as market participants waited for a permanent settlement of the Middle East geopolitical conflicts. Moreover, earnings results of some corporate bigwigs were
Bull of the Day: Quanta Services (PWR)
Quanta Services, Inc. PWR recently reported a record second quarter of 2026 and raised full year guidance as demand remains strong for power generation for the AI Revolution. This Zacks Rank #1
Relmada Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Relmada Therapeutics, Inc.? Here are five stocks we like better.
- NDV-01 manufacturing is Relmada’s immediate priority as it targets an investigational new drug
Is American Funds New World A (NEWFX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for Non US - Equity funds, you might want to consider passing on by American Funds New World A (NEWFX) as a possibility. NEWFX holds a Zacks Mutual Fund Rank of 4
Is MFS Growth Fund A (MFEGX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for Large Cap Growth funds, consider MFS Growth Fund A (MFEGX) as a possibility. MFEGX holds a Zacks Mutual Fund Rank of 2 (Buy), which is based on various forecasting
Buy 2 SS&C ALPS Mutual Funds for Risk-Adjusted Returns
SS&C ALPS Advisors is a U.S.-based asset management company offering a broad range of mutual funds that fall into three categories: sustainable income, thematic, and alternative growth strategies
AAOI Q2 Earnings Call Focuses on Capacity-Led 800G Ramp
Applied Optoelectronics, Inc. AAOI used its second-quarter 2026 earnings call to frame production capacity, rather than end demand, as the main limiter on near-term growth. CEO Thompson Lin said
Does Patterson-UTI (PTEN) Have the Potential to Rally 37.91% as Wall Street Analysts Expect?
Patterson-UTI (PTEN) closed the last trading session at $10.05, gaining 6.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Motorola (MSI) Just Flashed Golden Cross Signal: Do You Buy?
Motorola Solutions, Inc. (MSI) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MSI's 50-day simple moving average crossed
Should You Buy Wex (WEX) After Golden Cross?
WEX Inc. (WEX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, WEX's 50-day simple moving average crossed above its 200-day
Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect?
Iovance Biotherapeutics (IOVA) closed the last trading session at $6.21, gaining 42.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Manhattan Associates (MANH) is a Top-Ranked Momentum Stock: Should You Buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec Inc. IOSP reported second-quarter 2026 adjusted earnings of $1.27 per share, up 0.8% year over year. The figure beat the Zacks Consensus Estimate of $1.05 by 21%.Net income (as reported)
Ultrapar Participacoes S.A. (UGP) Recently Broke Out Above the 20-Day Moving Average
Ultrapar Participacoes S.A. (UGP) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, UGP crossed above the 20-day moving
Wall Street Analysts See Lam Research (LRCX) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm


